Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s): PCLOF

Financial Services Healthcare Asset Management

PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo... see more

Add To Watchlist

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Enters Spanish Market with Initial Shipment of 300 kg of CBD Full Spectrum Oil to Pharmaceutical Company

Canada NewsWire May 24, 2022

PharmaCielo Provides Update on Non-Brokered Private Placement of Debenture Units

Canada NewsWire May 11, 2022

PharmaCielo partners with Soteria Holdings Limited to license, import and wholesale its medical cannabis flower and extracts in the Polish market

Canada NewsWire May 6, 2022

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2021

Canada NewsWire April 29, 2022

Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried Flower

Canada NewsWire April 4, 2022

PharmaCielo Provides Update on Non-Brokered Private Placement of Debenture Units

Canada NewsWire March 4, 2022

/R E P E A T -- Colombian Government Passes Regulation to Enable Dried Flower Export and Expand Industrial Applications for CBD-Based Products/

PR Newswire February 22, 2022

Colombian Government Passes Regulation to Enable Dried Flower Export and Expand Industrial Applications for CBD-Based Products

PR Newswire February 20, 2022

PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany

PR Newswire February 14, 2022

PharmaCielo Provides Update on Latin American Sales Progress and Non-Brokered Private Placement of Debenture Units

PR Newswire February 4, 2022

PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units

PR Newswire December 31, 2021

PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units

PR Newswire December 22, 2021

PharmaCielo Announces Q3-2021 Financial Results

PR Newswire November 29, 2021

PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification

GlobeNewswire September 14, 2021

PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company's Board

PR Newswire September 1, 2021

PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO

PR Newswire August 20, 2021

PharmaCielo Signs Sales Agreement and Makes Initial Commercial Sale to Pharmaceutical Player in Brazil

PR Newswire August 4, 2021

PharmaCielo Welcomes Colombian Government's New Cannabis Decree

PR Newswire July 26, 2021

PharmaCielo to Participate in the Cantor Fitzgerald International Cannabis Forum

Canada NewsWire June 23, 2021

PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company

Canada NewsWire June 15, 2021